China Resources Jiangzhong Pharmaceutical Co (SHSE:600750) Marketable Securities: ¥247 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600750 China Resources Jiangzhong Pharmaceutical Co Ltd SHSE:600750
87 GF Score
Price ¥23.26
GF Value ¥20.80
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is China Resources Jiangzhong Pharmaceutical Co Marketable Securities?

China Resources Jiangzhong Pharmaceutical Co SHSE:600750 -2.19% 87 Marketable Securities is ¥247 Mil as of Jun. 2026. GuruFocus rates SHSE:600750 with a GF Score™ of 87/100 and a GF Value™ of ¥20.80 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. China Resources Jiangzhong Pharmaceutical Co's Marketable Securities for the quarter that ended in Jun. 2026 was ¥247 Mil.

China Resources Jiangzhong Pharmaceutical Co's annual Marketable Securities declined from Dec. 2023 (¥50 Mil) to Dec. 2024 (¥10 Mil) but then increased from Dec. 2024 (¥10 Mil) to Dec. 2025 (¥95 Mil).

China Resources Jiangzhong Pharmaceutical Co  (SHSE:600750) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

China Resources Jiangzhong Pharmaceutical Co Marketable Securities Related Terms

China Resources Jiangzhong Pharmaceutical Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for China Resources Jiangzhong Pharmaceutical Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Resources Jiangzhong Pharmaceutical Co Marketable Securities Chart

China Resources Jiangzhong Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,727.69 1,372.85 50.02 10.01 95.10

China Resources Jiangzhong Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.04 110.23 95.10 100.09 247.27
SHSE:600750
87GF Score
China Resources Jiangzhong Pharmaceutical Co Ltd SHSE:600750
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Resources Jiangzhong Pharmaceutical Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥247 Mil mean?
China Resources Jiangzhong Pharmaceutical Co (SHSE:600750) has a Marketable Securities of ¥247 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on China Resources Jiangzhong Pharmaceutical Co and its competitors.
Is China Resources Jiangzhong Pharmaceutical Co's Marketable Securities too high?
China Resources Jiangzhong Pharmaceutical Co's current Marketable Securities is ¥247 Mil. Overall, China Resources Jiangzhong Pharmaceutical Co has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Resources Jiangzhong Pharmaceutical Co's Marketable Securities compare to ZTS?
China Resources Jiangzhong Pharmaceutical Co's Marketable Securities of ¥247 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on China Resources Jiangzhong Pharmaceutical Co and its competitors. China Resources Jiangzhong Pharmaceutical Co's current Marketable Securities is ¥247 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Jiangzhong Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, China Resources Jiangzhong Pharmaceutical Co (SHSE:600750) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥20.80, compared to a current price of ¥23.26 — trading 11.8% above its estimated fair value. The current Marketable Securities is ¥247 Mil. China Resources Jiangzhong Pharmaceutical Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For China Resources Jiangzhong Pharmaceutical Co (SHSE:600750), the current Marketable Securities is ¥247 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Resources Jiangzhong Pharmaceutical Co (SHSE:600750) Overvalued in 2026?

Based on GuruFocus' analysis, China Resources Jiangzhong Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥23.26 is trading 11.8% above its estimated GF Value™ of ¥20.80. GuruFocus considers China Resources Jiangzhong Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for SHSE:600750:

  • Marketable Securities: ¥247 Mil
  • GF Value™: ¥20.80 vs. price of ¥23.26 (11.8% above fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Resources Jiangzhong Pharmaceutical Co Business Description

Address No. 788, Torch Avenue, High-tech Zone, Jiangxi Province, Nanchang, CHN, 330096
China Resources Jiangzhong Pharmaceutical Co Ltd is engaged in the research and development, production, and sale of over-the-counter pharmaceuticals and health-related products, including functional foods. Its business activities also include the production and sale of proprietary Chinese medicines and chemical drugs.
87GF Score

Get the complete analysis for SHSE:600750

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥23.26
Price
¥20.80
GF Value